Bioequivalence study of Glimepride Tablet [Study As­sess­ment]

posted by Ibrahim Komeil – Egypt, 2021-02-15 09:07 (60 d 21:17 ago) – Posting: # 22208
Views: 401

Dear All
I hope you are all fine
Recently i had got results of bioequivalence study for Glimepride Tablet 1 mg applying two way crossover design with 26 volunteers
The results are shown below:
Cmax: PI = 0.75, 90% CI [0.672 - 0.845]
AUCt:  PI = 0.82, 90% CI [0.754 - 1.042]

I am confusing to be sure that the test product is bad , so i am asking your help to know the real cause of these results.

Thank you in advance

Edit: Category changed; see also this post #1[Helmut]

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 9 (0 registered, 9 guests [including 3 identified bots]).
Forum time: Saturday 06:25 UTC (Europe/Vienna)

I never did anything worth doing by accident,
nor did any of my inventions come by accident;
they came by work.    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz